International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 10.21.2021
woman uses laptop in kitchen
car t cell up close
Nurse Leadership Board Publishes on CAR T-Cell Therapy, Cilta-cel
This past summer, the IMF Nurse Leadership Board (NLB) met to discuss the latest clinical data for cilta-cel, a novel BCMA-targeted CAR-T therapy, in the treatment of patients with multiple myeloma (MM). The NLB identified specific educational needs as they reviewed safety and patient management approaches for CAR-T therapies. Read the full publication using the link below.
Living Well Global Collaboration Webinar
Global Collaborations Bringing Us Closer to a Cure — A Webinar Not to Be Missed!
Today’s “Living Well with Myeloma” webinar happens at 4 p.m. PT / 7 p.m. ET. During this webinar, IMF Chairman of the Board Dr. Brian G.M. Durie will explain the collaborative IMF’s Global Technology Platform, comprised of seven major myeloma research teams. Each team is simultaneously pursuing diverse routes to identify and achieve both prevention and a cure for myeloma. At the end of the presentation, Dr. Durie will answer your questions.
register button
patient family webinar with speakers
Register for This Multiple Myeloma Webinar for Patients and Their Families
Register for the  October 30th Patient and Family Webinar at 7 a.m. PT / 9 a.m. CT / 10 a.m. ET. It will focus on “Advances in Myeloma Treatments: What Patients & Caregivers Need to Know.”  IMF Chairman Dr. Brian G.M. Durie will moderate presentations with IMF Nurse Leadership Board Member Teresa Miceli RN, BSN, OCN® (Mayo Clinic — Rochester, MN); Adam Cohen, MD (University of Pennsylvania Perelman School of Medicine — Philadelphia); Paul Richardson, MD (Dana-Farber Cancer Institute — Boston); and IMF Vice President of Support Groups Robin Tuohy. Attendees will learn what the latest advancements in myeloma research mean for patients, how to better manage side effects, optimal choices for relapsed patients, and more. At the end of the presentations, participants will have time to ask questions.
register button
nurse workshop imw 2021 banner
Join a FREE On-Demand Event from the International Myeloma Workshop (IMW) Nurses' Meeting
Attention nurses: Join a free on-demand event from the 18th IMW Nurse Workshop, which will benefit you and the patients you care for! Side effect management and the unique considerations associated with the delivery of new drugs will be discussed. Register now for this complimentary virtual event. If you have trouble with link, email:
register button
m power atlanta banner
Changing the Course of Myeloma in the African-American Community
The IMF’s M-Power Initiative is focused on changing the course of myeloma in the African-American community, especially since myeloma is two times as common in people of African descent as it is in all other races and ethnicities. To learn how to empower yourself, join the next M-Power workshop for the Atlanta area on Saturday, November 13, at 10 a.m. ET. The event panelists will include Dr. Ajay K. Nooka (Winship Cancer Institute, Emory University — Atlanta); IMF Nurse Leadership Board Member Charise Gleason, MSN, NP-C, AOCNP® (Winship Cancer Institute, Emory University — Atlanta); myeloma patient and advocate Jameca Barrett; and IMF Chief Medical Officer Dr. Joseph Mikhael (TGen at the City of Hope — Phoenix).
register button
ask doctor durie video image
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

What should myeloma patients do when a low level of myeloma protein remains detectable?
Watch Now
Clinical Trial Fact Sheets

Smart Patients: Join the Conversation

CANOVA Trial (Accruing)

NCT02899052 Trial (Accruing)

NCT03314181 Trial (Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)
Upcoming Events & Replays
Donate Now
Sim Racing Winter Challenge

Watch the Replay
COVID-19 and Myeloma Webinar

Watch the Replay
Financial Resources Webinar

Click here to see all events

We Thank Our Sponsors:

Amgen, Bristol Myers Squibb, Karyopharm Therapeutics, Oncopeptides Inc.,
Sanofi-Genzyme, and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page